Approximately 30% of patients who underwent radical prostatectomy or radiation therapy will develop biochemical recurrent disease.
Biochemical recurrent disease is defined as an increase in the serum value of prostate-specific antigen (PSA) after reaching the nadir. Prostate recurrence can present as PSA-only relapse, local recurrent disease, distant metastases, or a combination of local and distant recurrence. In this review, the role of magnetic resonance imaging in the work-up of recurrent prostate cancer is discussed.
Written by:
Fütterer JJ. Are you the author?
Department of Radiology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, Internal Postal Code 766, 6500 HB Nijmegen, The Netherlands; MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, P.O. Box 217, 7500 AE Enschede, The Netherlands.
Reference: Radiol Clin North Am. 2012 Nov;50(6):1075-83.
doi: 10.1016/j.rcl.2012.08.005
PubMed Abstract
PMID: 23122039
UroToday.com Prostate Cancer Section
